Cargando…

Clinical utility of procalcitonin in febrile infants younger than 3 months of age visiting a pediatric emergency room: a retrospective single-center study

BACKGROUND: Fever in infants under 90 days of age is highly likely to be caused by a severe bacterial infection (SBI) and it accounts for a large number of patients visiting the pediatric emergency room. In order to predict the bacterial infection and reduce unnecessary treatment, the classic classi...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Jun-Sung, Byun, Young-Hoon, Lee, Jeong-Yong, Lee, Jong Seung, Ryu, Jeong-Min, Choi, Seung Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7931518/
https://www.ncbi.nlm.nih.gov/pubmed/33663442
http://dx.doi.org/10.1186/s12887-021-02568-5
_version_ 1783660311154262016
author Park, Jun-Sung
Byun, Young-Hoon
Lee, Jeong-Yong
Lee, Jong Seung
Ryu, Jeong-Min
Choi, Seung Jun
author_facet Park, Jun-Sung
Byun, Young-Hoon
Lee, Jeong-Yong
Lee, Jong Seung
Ryu, Jeong-Min
Choi, Seung Jun
author_sort Park, Jun-Sung
collection PubMed
description BACKGROUND: Fever in infants under 90 days of age is highly likely to be caused by a severe bacterial infection (SBI) and it accounts for a large number of patients visiting the pediatric emergency room. In order to predict the bacterial infection and reduce unnecessary treatment, the classic classification system is based on white blood cell (WBC) count, urinalysis, and x-ray, and it is modified and applied at each center by incorporating recently studied biomarkers such as c-reactive protein (CRP) or procalcitonin (PCT). This study analyzed the usefulness of PCT in predicting SBI when applied along with the existing classification system, including CRP, among infants less than 90 days old who visited with a fever at a single institution pediatric emergency center. METHODS: We retrospectively reviewed the medical records of patients younger than 3 months of age who presented with fever at the Seoul Asan Medical Center pediatric emergency room between July 2017 and October 2018. RESULTS: A total of 317 patients were analyzed, and 61 were diagnosed with SBI, among which urinary tract infection (UTI) accounted for the largest proportion (55/61, 90.2%). There were differences in WBC, neutrophil proportion, CRP, and PCT between the SBI group and the non-SBI group, and the AUC values of WBC, CRP, and PCT were 0.651, 0.804, and 0.746, respectively. When using the cut-off values of CRP and PCTs as 2.0 mg/dL and 0.3 ng/mL, respectively, the sensitivity and specificity for SBI were 49.2/89.5, and 54.1/87.5, respectively. WBC, CRP, and PCT were statistically significant for predicting SBI in multivariate analysis (odds ratios 1.066, 1.377, and 1.291, respectively). When the subjects were classified using the existing classification criteria, WBC and CRP, the positive predictive value (PPV) and negative predictive value (NPV) were 29.3 and 88.7%, respectively, and when PCT was added, the PPV and NPV were 30.7 and 92%, respectively, both increased. CONCLUSION: PCT is useful for predicting SBI in children aged 3 months or less who visit the emergency room with a fever. It is useful as a single biomarker, and when used in conjunction with classic biomarkers, its diagnostic accuracy is further increased.
format Online
Article
Text
id pubmed-7931518
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-79315182021-03-05 Clinical utility of procalcitonin in febrile infants younger than 3 months of age visiting a pediatric emergency room: a retrospective single-center study Park, Jun-Sung Byun, Young-Hoon Lee, Jeong-Yong Lee, Jong Seung Ryu, Jeong-Min Choi, Seung Jun BMC Pediatr Research Article BACKGROUND: Fever in infants under 90 days of age is highly likely to be caused by a severe bacterial infection (SBI) and it accounts for a large number of patients visiting the pediatric emergency room. In order to predict the bacterial infection and reduce unnecessary treatment, the classic classification system is based on white blood cell (WBC) count, urinalysis, and x-ray, and it is modified and applied at each center by incorporating recently studied biomarkers such as c-reactive protein (CRP) or procalcitonin (PCT). This study analyzed the usefulness of PCT in predicting SBI when applied along with the existing classification system, including CRP, among infants less than 90 days old who visited with a fever at a single institution pediatric emergency center. METHODS: We retrospectively reviewed the medical records of patients younger than 3 months of age who presented with fever at the Seoul Asan Medical Center pediatric emergency room between July 2017 and October 2018. RESULTS: A total of 317 patients were analyzed, and 61 were diagnosed with SBI, among which urinary tract infection (UTI) accounted for the largest proportion (55/61, 90.2%). There were differences in WBC, neutrophil proportion, CRP, and PCT between the SBI group and the non-SBI group, and the AUC values of WBC, CRP, and PCT were 0.651, 0.804, and 0.746, respectively. When using the cut-off values of CRP and PCTs as 2.0 mg/dL and 0.3 ng/mL, respectively, the sensitivity and specificity for SBI were 49.2/89.5, and 54.1/87.5, respectively. WBC, CRP, and PCT were statistically significant for predicting SBI in multivariate analysis (odds ratios 1.066, 1.377, and 1.291, respectively). When the subjects were classified using the existing classification criteria, WBC and CRP, the positive predictive value (PPV) and negative predictive value (NPV) were 29.3 and 88.7%, respectively, and when PCT was added, the PPV and NPV were 30.7 and 92%, respectively, both increased. CONCLUSION: PCT is useful for predicting SBI in children aged 3 months or less who visit the emergency room with a fever. It is useful as a single biomarker, and when used in conjunction with classic biomarkers, its diagnostic accuracy is further increased. BioMed Central 2021-03-04 /pmc/articles/PMC7931518/ /pubmed/33663442 http://dx.doi.org/10.1186/s12887-021-02568-5 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Park, Jun-Sung
Byun, Young-Hoon
Lee, Jeong-Yong
Lee, Jong Seung
Ryu, Jeong-Min
Choi, Seung Jun
Clinical utility of procalcitonin in febrile infants younger than 3 months of age visiting a pediatric emergency room: a retrospective single-center study
title Clinical utility of procalcitonin in febrile infants younger than 3 months of age visiting a pediatric emergency room: a retrospective single-center study
title_full Clinical utility of procalcitonin in febrile infants younger than 3 months of age visiting a pediatric emergency room: a retrospective single-center study
title_fullStr Clinical utility of procalcitonin in febrile infants younger than 3 months of age visiting a pediatric emergency room: a retrospective single-center study
title_full_unstemmed Clinical utility of procalcitonin in febrile infants younger than 3 months of age visiting a pediatric emergency room: a retrospective single-center study
title_short Clinical utility of procalcitonin in febrile infants younger than 3 months of age visiting a pediatric emergency room: a retrospective single-center study
title_sort clinical utility of procalcitonin in febrile infants younger than 3 months of age visiting a pediatric emergency room: a retrospective single-center study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7931518/
https://www.ncbi.nlm.nih.gov/pubmed/33663442
http://dx.doi.org/10.1186/s12887-021-02568-5
work_keys_str_mv AT parkjunsung clinicalutilityofprocalcitonininfebrileinfantsyoungerthan3monthsofagevisitingapediatricemergencyroomaretrospectivesinglecenterstudy
AT byunyounghoon clinicalutilityofprocalcitonininfebrileinfantsyoungerthan3monthsofagevisitingapediatricemergencyroomaretrospectivesinglecenterstudy
AT leejeongyong clinicalutilityofprocalcitonininfebrileinfantsyoungerthan3monthsofagevisitingapediatricemergencyroomaretrospectivesinglecenterstudy
AT leejongseung clinicalutilityofprocalcitonininfebrileinfantsyoungerthan3monthsofagevisitingapediatricemergencyroomaretrospectivesinglecenterstudy
AT ryujeongmin clinicalutilityofprocalcitonininfebrileinfantsyoungerthan3monthsofagevisitingapediatricemergencyroomaretrospectivesinglecenterstudy
AT choiseungjun clinicalutilityofprocalcitonininfebrileinfantsyoungerthan3monthsofagevisitingapediatricemergencyroomaretrospectivesinglecenterstudy